Buy Ipamorelin 10mg Online

IGF-1 LR3 is a synthetic insulin-like growth factor analog designed for research with enhanced receptor binding and extended half-life. Research suggests it may support cell growth and protein synthesis by prolonging IGF-1 receptor activation. Moreover, it may work by reducing interactions with binding proteins while maintaining IGF-1 signaling pathways.

$55.00

General info
Brand

NOVERA COMPOUNDS

Strength

10mg

CAS

170851-70-4

Chemical Formula

C₃₈H₄₉N₉O₅

Molecular weight

711.9 g/mol

Peptide Sequence

Aib–His-D-2Nal-D-Phe-Lys

Synonyms

Ipamorelin Acetate

Storage

Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.

Shelf life

24 months from the manufacturing date.

IGF-1 LR3 (1mg) About This Product

The IGF-1 peptide, specifically IGF-1 LR3 (Long Arg³ insulin-like growth factor-1), is a synthetic analogue of native human insulin-like growth factor-1 developed for controlled laboratory research. Laboratories that buy IGF-1 peptide or order IGF-1 peptide materials reference IGF-1 LR3 for experimental studies examining IGF signaling behavior and binding-protein interactions in research systems.

IGF-1 LR3 consists of 83 amino acids and has a molecular weight of approximately 9,117.5 g/mol. Compared with endogenous IGF-1, which contains 70 amino acids, this analogue includes a 13-amino-acid N-terminal extension and a single amino acid substitution at position 3. These structural modifications reduce interaction with insulin-like growth factor binding proteins (IGFBPs), particularly IGFBP-3, a property examined in comparative laboratory studies.

The product is supplied as a lyophilized powder in 1 mg glass vials, commonly produced at ≥95–99% purity as verified by analytical testing, and intended exclusively for laboratory research use.

IGF-1 LR3 (1mg) Key Features and Benefits

  • Chemical identity: Modified IGF-1 analogue (IGF-1 LR3)
  • Amino acid length: 83 amino acids
  • Molecular weight: ~9,117.5 g/mol
  • Purity: Commonly reported at ≥95–99%, verified by analytical methods
  • Format: Supplied as a lyophilized powder in sterile glass vials
  • Binding characteristics: Reduced interaction with IGF binding proteins compared with native IGF-1
  • Research scope: Studied in laboratory models examining IGF receptor signaling and cellular response patterns

For laboratory research use only.

IGF-1 LR3 (1mg) Mechanism & Research Applications

IGF-1 LR3 has been examined in laboratory research as a modified IGF-1 variant evaluated for its interaction with the IGF-1 receptor under controlled experimental conditions. Due to reduced IGFBP binding, the peptide is used in research systems to explore IGF signaling behavior with altered binding-protein modulation.

Research applications include:

  • IGF receptor signaling studies in cell culture models
  • Comparative binding investigations assessing IGF-1 variants and IGFBP interactions
  • Muscle, adipocyte, and developmental cell systems used for experimental signaling analysis
  • Preclinical growth-factor research models evaluating short-term cellular response markers

All applications described reflect controlled laboratory research contexts and do not imply clinical or therapeutic use.

IGF-1 LR3 (1mg) Dosing & Observed Effects in Research

Reported research use of IGF-1 LR3 varies across experimental designs, model systems, and analytical endpoints. In in vitro studies, the peptide is typically evaluated at nanogram-per-milliliter concentrations, with working ranges adjusted based on cell type and assay requirements.

Preclinical animal research has explored experimental infusion and exposure protocols to assess IGF-related signaling markers, cellular response patterns, and other assay-specific molecular readouts. These observations are derived exclusively from controlled laboratory and animal research environments and do not establish safety, efficacy, or clinical relevance.

Researchers who order IGF-1 peptide materials are expected to define experimental parameters appropriate to their specific model systems.

IGF-1 LR3 (1mg) Storage, Safety & References

  • Store lyophilized vials at –18 °C to –20 °C, protected from light and moisture
  • Maintain vials in a desiccated environment when not in use
  • Reconstitute only with sterile water, PBS, or appropriate laboratory media using aseptic technique
  • Store reconstituted solutions at 2–8 °C for short-term use
  • For extended storage, aliquot and freeze at –20 °C or –80 °C
  • Avoid repeated freeze–thaw cycles

Handle materials according to institutional laboratory biosafety protocols.

References

https://pubmed.ncbi.nlm.nih.gov/22682628

https://academic.oup.com/edrv/article/44/5/753/7090400

https://pubmed.ncbi.nlm.nih.gov/11181549

https://pmc.ncbi.nlm.nih.gov/articles/PMC2409634

https://pmc.ncbi.nlm.nih.gov/articles/PMC2121039

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.

All clinical and product claims on this page have been checked against peer-reviewed research, manufacturer data, and regulatory sources in accordance with our Editorial Policy .